The efficacy of GIP(3-30)NH2 as a GIP receptor antagonist in humans: [Meeting Abstract}

Publikation: Bidrag til tidsskriftKonferenceartikelForskning

OriginalsprogEngelsk
Artikelnummer557
TidsskriftDiabetologia
Vol/bind62
Udgave nummerSupæ. 1/SI
Sider (fra-til)S269-S269
ISSN0012-186X
StatusUdgivet - 2019
Begivenhed55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) - Barcelona, Spanien
Varighed: 16 sep. 201920 sep. 2019

Konference

Konference55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
LandSpanien
ByBarcelona
Periode16/09/201920/09/2019

ID: 230571329